What genetic mutations are associated with Lynch syndrome, and how do they contribute to cancer risk?
Lynch syndrome is associated with mutations in MLH1, MSH2, MSH6, PMS2, and EPCAM genes, leading to defective mismatch repair and increased cancer risk. Genetic testing is pivotal for risk management and guiding tailored cancer surveillance and treatment strategies.
Authors
- Tripdatabase
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.5281/zenodo.24234983
- Primary Topic
- Genetic factors in colorectal cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00